# A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

> clinical trial · VERIFIED · 2026-08-27

Status: RECRUITING · Sponsor: UCB Biopharma SRL · Condition: Palmoplantar Pustulosis

- Company: UCB Biopharma SRL
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07219420

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.